TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/06/2024
Back to search
Official data from USPTO
NKMAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
12/10/2024
Trademark type
Word
Nice classes
5, 42
Filing date
11/11/2021
Registration date
08/22/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/22/2023
Last transaction
12/10/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/05/2019
First use in commerce
08/05/2019
Drawing code
4
Owner type
99
Owner location
Gyeonggi-do, KR
Examiner
COGAN, BRITTNEY
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NKMAX CO., LTD.
Representatives
Deborah L. Corpus Chrisman Gallo Tochtrop LLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for animals for regulating the immune system and treating cancer; pharmaceutical preparationsimmunomodulators; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of cells for regulating the immune system and treating cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; biopharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; stem cells for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of immune system related diseases and disorders
Class 42
Development of cell therapy products; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes; medical and pharmacological research services; medical research services; development of biotechnology products; biotechnological research; cell separation research services; technological research in the field of cell therapymedicinepharmacologybiotechnology
Publications
History of USPTO decisions and trademark events.
25 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/06/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/06/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/06/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/22/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/22/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/19/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/18/2023
DOCK
ASSIGNED TO EXAMINER
07/17/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/17/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/17/2023
IUAF
USE AMENDMENT FILED
04/27/2023
EISU
TEAS STATEMENT OF USE RECEIVED
04/27/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/20/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/25/2022
PUBO
PUBLISHED FOR OPPOSITION
10/25/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/19/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
08/25/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/25/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
08/25/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/25/2022
DOCK
ASSIGNED TO EXAMINER
08/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/18/2021
NWAP
NEW APPLICATION ENTERED
11/15/2021
Continuous trademark protection
Get notified about every new filing that threatens NKMAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.